Correlation Between Viatris and Teva Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and Teva Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Teva Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Teva Pharma Industries, you can compare the effects of market volatilities on Viatris and Teva Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Teva Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Teva Pharma.

Diversification Opportunities for Viatris and Teva Pharma

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Viatris and Teva is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Teva Pharma Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharma Industries and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Teva Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharma Industries has no effect on the direction of Viatris i.e., Viatris and Teva Pharma go up and down completely randomly.

Pair Corralation between Viatris and Teva Pharma

Given the investment horizon of 90 days Viatris is expected to generate 1.28 times more return on investment than Teva Pharma. However, Viatris is 1.28 times more volatile than Teva Pharma Industries. It trades about 0.07 of its potential returns per unit of risk. Teva Pharma Industries is currently generating about -0.1 per unit of risk. If you would invest  1,208  in Viatris on August 30, 2024 and sell it today you would earn a total of  114.00  from holding Viatris or generate 9.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  Teva Pharma Industries

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Teva Pharma Industries 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Teva Pharma Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Viatris and Teva Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and Teva Pharma

The main advantage of trading using opposite Viatris and Teva Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Teva Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharma will offset losses from the drop in Teva Pharma's long position.
The idea behind Viatris and Teva Pharma Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators